Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-25-004411
Filing Date
2025-10-15
Accepted
2025-10-15 13:24:20
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11585
  Complete submission text file 0000902664-25-004411.txt   14917
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-531-9088
ADAR1 Partners, LP (Reporting) CIK: 0001758866 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251394275

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address
Schneeberger Daniel (Reporting) CIK: 0001861120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251394273

Mailing Address 325 RANCH ROAD 620 SOUTH SUITE 200 AUSTIN TX 78738
Business Address 325 RANCH ROAD 620 SOUTH SUITE 200 AUSTIN TX 78738 512-531-9088
ADAR1 Capital Management GP, LLC (Reporting) CIK: 0001940267 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251394274

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Reporting) CIK: 0001940272 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 251394276